Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 15, 2023

SELL
$25.32 - $51.45 $1,063 - $2,160
-42 Reduced 47.19%
47 $2,000
Q3 2022

Nov 15, 2022

SELL
$46.5 - $79.14 $46 - $79
-1 Reduced 1.11%
89 $4,000
Q2 2022

Aug 15, 2022

BUY
$63.06 - $84.75 $819 - $1,101
13 Added 16.88%
90 $6,000
Q1 2022

May 11, 2022

SELL
$74.15 - $99.36 $1,112 - $1,490
-15 Reduced 16.3%
77 $6,000
Q4 2021

Mar 09, 2022

SELL
$86.01 - $102.89 $602 - $720
-7 Reduced 7.07%
92 $9,000
Q1 2021

Apr 28, 2021

SELL
$67.36 - $80.76 $606 - $726
-9 Reduced 8.33%
99 $8,000
Q4 2020

Feb 25, 2021

BUY
$53.08 - $69.86 $1,327 - $1,746
25 Added 30.12%
108 $7,000
Q3 2020

Nov 30, 2020

BUY
$51.29 - $65.09 $615 - $781
12 Added 16.9%
83 $6,000
Q2 2020

Aug 17, 2020

BUY
$34.32 - $62.43 $2,436 - $4,432
71 New
71 $4,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.